Quoin Pharmaceuticals, Ltd. (QNRX)

USD 5.28

(-1.68%)

Market Cap (In USD)

3.1 Million

Revenue (In USD)

-

Net Income (In USD)

-8.68 Million

Avg. Volume

260.76 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.477-6.18
PE
-0.08
EPS
-66.85
Beta Value
1.886
ISIN
US74907L3006
CUSIP
74907L102
CIK
1671502
Shares
588167.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Michael Myers Ph.D.
Employee Count
-
Website
https://quoinpharma.com
Ipo Date
2016-08-01
Details
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.